Preparing Your Aseptic Processing Facility for an FDA Inspection. Valerie Welter, Director Quality Bayer HealthCare March 10, 2014

Similar documents
FDA s Guidance for Industry

Aseptic Process Validation

for IND and RDRC Regulated PET Compounding

Overview of a sterility assurance program for PET drugs

On-Site GMP Training GMP COMPLIANCE TECHNICAL

Microbiological Consideration for Non-Sterile Pharmaceutical

Media Fill A Process Simution. Presented By Shikha Chauhan

USP Chapter 823 USP 32 (old) vs. USP 35 (new)

Sterile Compounding elearning Course Curriculum 28 lessons with 33 hours of CE. Fundamentals of Sterile Compounding (8 lessons/8 hours CE)

EU and FDA GMP Regulations: Overview and Comparison

MINIMUM REQUIREMENTS FOR A VENDOR

AAMI Quality Systems White Paper: Comparison of 21 CFR Part 820 to ISO 13485:2016 1

Review Validation of aseptic processes for pharmaceuticals

Julie Roberts. Audit hot Topics and Regulatory Requirements

PhEn-602 Notes # 4 J. Manfredi

CSV Inspection Readiness through Effective Document Control. Eileen Cortes April 27, 2017

Responding to an FDA 483

Annex A2. Guidance on Process Validation Scheme for Aseptically Processed Products

Aseptic Processing Current Issues & Trends

Hot Topics in Drug Product Process Validation: A Reviewer s Perspective

Metrics in Microbiology Monitoring Practices

Conducting Supplier Audits: Ensure Validation Compliance

Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer

Quality Agreements with CMO s. Presented at ASQ Orange Empire Meeting May 13, 2014 By Luke Foo Sr. Director QA/QC Spectrum Pharmaceuticals

Application of Quality Risk Management Tools for Cell Therapy Manufacturing

Inspections, Compliance, Enforcement, and Criminal Investigations

GMP On Site Series. GMP Essentials

Validation Study on How to Avoid Microbial Contamination during Pharmaceutical Production

Avoid recurrent microbial contamination using trending of historical data. El Azab Walid Technical Service Manager STERIS

Managing Your Environmental Isolates

USP <797> Compliance Common Challenges and Potential Solutions

Guidance. Media Fills for Validation of Aseptic Preparations for Positron Emission Tomography (PET) Drugs DRAFT GUIDANCE

STERILIZATION VALIDATION IN THIS SECTION REPROCESSING VALIDATIONS FOR REUSABLE MEDICAL DEVICES. Radiation Sterilization Validation

PDA: A Global. Association. Matrix Approach to Media Fills. (c) 2012 Catalent Pharma Solutions. All rights reserved.

Industry Perspective on Manufacturing in Early Development

Microbiology Research Associates

Is it true, Annex 1 revision will have no impact on resources or cost? Walid El Azab Technical Service Manager STERIS

18.H Questionnaire for preparing GMP-inspections

Trinity College Dublin QP Forum 2017 Tuesday 25 th April

Validation. An Easy to Understand Guide Validating Purified Water Systems

Quality Risk Management (ICH Q9): WHO Model for Sustainable Quality Medicines

General European OMCL Network (GEON) QUALITY MANAGEMENT DOCUMENT

PCI Pharmaceutical Consulting

Basics Of Labwasher Cleaning Validation

WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer. Mylan Nashik ( Sinnar in CRM) AND

Audits and Inspections

Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer

DISINFECTION QUALIFI CATION TESTING CONSIDERATIONS FOR THE ASEPTIC AND CLEANROOM MANUFACTURING ENVIRONMENT

Microbiological Cleaning Method Validation

Validation of Sterilizing Grade Filters

The 10 Golden Rules of GMP

GxP Auditing, Remediation, and Staff Augmentation

PRAXIS. A publication by Bioengineering AG

Medical Device Purchasing Controls Challenges of Compliance in a World Market June, 2013 OMTEC

Continuous Pharmaceutical Manufacturing: CGMP, Process Validation, and Inspectional Considerations for Implementation

GxP Auditing, Remediation, and Staff Augmentation

GxP Auditing, Remediation, and Quality System Resourcing

CGMP for Phase 1 INDs

Isolators v. RABS: Facility Design Considerations for a Fill-Finish Finish Suite

sterility assurance Prove the power and your processes

The largest network of harmonized bio/ pharmaceutical GMP product testing labs worldwide, Eurofins BioPharma Product Testing enables companies to

Guidance for Industry Sterile Drug Products Produced by Aseptic Processing Current Good Manufacturing Practice

The Parenteral Drug Association

REUSABLE MEDICAL DEVICE VALIDATION

Compounding Pharmacies and the Contract Testing Lab

Guidelines for Process Validation of Pharmaceutical Dosage Forms

This compilation of the complex

USP <1116> and Contamination

GMPs: Distribution Centers

MEASURE FOR MEASURE: QUALITY METRICS

GMP MANUAL Contents. Contents (1) 1 Pharmaceutical Quality System (PQS) 2 Personnel

Harmonizing FDA Regulation and the Practice of Pharmacy: Challenges and Opportunities. Plus an update on PET Drug User Fees

Correspondence Between ISO 13485:2016 and 21 CFR Part 820 QMS Requirements

Analytical and formulation attributes

LEGAL REQUIREMENTS FOR STABILITY

Standard operating procedures revisited: a 2014 perspective

October 10, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm Rockville, MD 20852

Facility and Equipment Maintenance

Quality Assurance of RUTF and similar products. Future areas of focus!

How to Hit the Easy Button for a FSMA-Compliant Food Safety Plan

CUSTOMER AND SUPPLIER ROLES AND RESPONSIBILITIES FOR 21 CFR 11 COMPLIANCE ASSESSMENT. 21 CFR Part 11 FAQ. (Frequently Asked Questions)

A.1 Contents file 4 to 5 A.1 (1)

WHITE PAPER. Food Safety, From Farm to Fork. A Best-Practice Approach to Implementing a Food Safety Management System

ASQ Tappan Zee Section Medical Devices, New Regulations and Standards. 26 th September / V. Fischer / Rev. 01

Efficient Validation Strategies and VMPs

Compounding Aseptic Isolators (CAI) James T Wagner

Introduction to GMPs and Validation WILLIAM GARVEY AND ASSOCIATES

PAT & Risk-Based Initiatives: Implementation Issues PDA New England - 8 th Dec Cliff Campbell B.E., C.Eng. CC&A Ltd., Cork, Ireland

Handling OOS, OOT and Unexpected Results. Karen Ginsbury PCI Pharmaceutical Consulting Israel Ltd for IFF, October 2017

Combination Products Part 4 Compliance and Implementation at multi-site Network

PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7:NON-STERILE PROCESS VALIDATION

Best Practices and Application of GMPs for Small Molecule Drugs in Early Development IQ Workshop, Feb 4-5, 2014, Washington, D.C.

GMP In-house Training

Advancements on implementation of single use technology in vaccine manufacturing

Quality Assurance for the Research Team: Connecting Day-to-Day Operations to a Regulatory Framework

OOS: Back to Basics. Compliant, Effective, Efficient PATH

Quality & Regulatory Issues in Biopharmaceutical Facility Design A Perspective from Industry Trends

Single-Use Final Fill: Benefits and Considerations

Your partner in the pharmaceutical industry

Understanding GxP Regulations for Healthcare

Transcription:

Preparing Your Aseptic Processing Facility for an FDA Inspection Valerie Welter, Director Quality Bayer HealthCare March 10, 2014

Agenda Regulatory Requirements Establishing your Approach Aseptic Controls Master Plan Media Fill Protocol Executive Summary Reports Preparing Your Facility 1 st Impressions Process, Material, Personnel Tour Routes Planned Operations Preparing Your Employees Competencies Subject Matter Experts The Art of Audit Facilitation Interactive Exercise; Learn from the Mistakes of Others 2

Expectations are Just That.Expected 3

Regulatory Requirements & Expectations GMP s: 21 CFR Part 210/ 211 211.113 (b) validation of aseptic processing prevention of microbial contamination 211.110 (a) inclusion of Bioburden testing as an in-process test FDA s Aseptic Processing Guideline: Sterile Drugs & Biologics FDA Compliance Manual, Chapter 56 Drug Quality Assurance 7356.002A ISO: ISO 14644-1:1999 Clean rooms and associated controlled environments: Part 1: Classification of air cleanliness 14644-2:2000 Clean rooms and associated controlled environments: Part 2: Specifications for testing and monitoring to prove continued compliance with ISO 14644-1 ORA: ORA-Lab.5.3; Facilities and Environmental Conditions: Defines requirements for FDA/ORA laboratories CDRH / QSR: 21 CFR Part 820- Production & Process Controls: Adequate control of environmental and personnel to assure no adverse effect on product quality USP: Monographs specific to execution of Microbiological Testing; General chapters are strongly encouraged to be adopted. Many More.. 4

Key to Success: State of Control ICH Q-10 Pharmaceutical Quality System Achieve Product Realization Establish and Maintain a State of Control Facilitate Continual Improvement FDA-Compliance Program Guidance Manual; Chapter 56 Drug Quality Assurance Program 7356.002A: Sterile Drug Process Inspections 5

The Design of your Controlled Environments will dictate the Elements of your Control Strategy 6

Aseptic Controls Master Plan The purpose of the Prevention of Microbial Contamination and Aseptic Processing Controls Master Plan is to direct and document the general principles, responsibilities, and procedures to ensure that the appropriate microbial contamination prevention and aseptic processing control measures are in place to mitigate risk of contamination. This Master Plan details the approach to ensure that sterile drug products manufactured using aseptic processing meet the requirements of the current good manufacturing (cgmp) regulations (2l CFR parts 210 and 211) 7

Roadmap to Compliance Purpose Scope References Definitions Responsibilities General Principles supporting your Sites State of Control Facilities and Equipment Personnel & Training Starting Materials Aseptic Processing Environmental, Personnel, Utility Monitoring 8

Key Partnerships Supply Chain Engineering Manufacturing Quality Unit Validation Technical Services Facility Cleaning and Sanitization Group 9

Responsibilities Supply Chain Source and purchase materials of appropriate microbial and handling quality Ensure proper storage and handling of all raw materials, components and finished products Engineering Assure facilities are designed, controlled and monitored to provide the appropriate level of contamination control 10

Responsibilities Manufacturing Ensure personnel are appropriately trained and qualified and report any adverse medical conditions to mgt. Execute manufacturing instructions per approved quality records Assure environmental and procedural controls are enforced Execute Aseptic Processing Simulations 11

Responsibilities Quality Unit Ensure personnel are appropriately trained and qualified and report any adverse medical conditions to mgt. SME s for: Cleaning/Sanitization of Facility, Environmental Controls Plan, Aseptic Gowning Certification, Aseptic Processing Simulations, Provide Quality Oversight to the Aseptic Process 12

Responsibilities Validation / Technical Services Facility Qualification Equipment Qualification Aseptic Processing Simulations Container Closure Validation Cleaning Validation Facility Sanitization Personnel Do not underestimate the criticality of this group Must be trained in contamination risk mitigation 13

Responsibilities Management Ensure appropriate Microbial Controls are in place Ensure a diverse array of control measures are implemented in order to mitigate risk Ensure that adequate resources are available and that personnel are adequately trained to perform their assigned function 14

General Principles Define everything and anything that you consider relevant to the State of Aseptic Control of your facility Bullets only...see Bonus Material Facilities and Equipment Personnel & Training Starting Materials Aseptic Processing Environmental, Personnel, Utility Monitoring 15

The Media Fill Protocol Follow your standard Process Validation Protocol Format Purpose Scope References Responsibilities Procedures and Acceptance Criteria Steal Shamelessly from Aseptic Processing Guidance Batch Record must represent Routine Process 16

The Media Fill Protocol Attachment 1 Protocol Discrepancy Log Attachment 2 Protocol Discrepancy Form Attachment 3 Signature Log Attachment 4 Training Checklist Attachment 5 Interim Read Attachment 6 Final Read Attachment 7 Growth Promotion/Fill Volume Attachment 8 Contamination Rate and Pass/Fail Results Attachment 9 Accountability Attachment 10 Growth Promotion Results Attachment 11 QC Microbiology Test Forms Attachment 12 Batch Records Attachment 13 Routine/Non Routine Interventions and Aseptic Technique Log 17

Protocol Test Plan Pulling the dynamic components out of the Protocol No. of Runs Components Line Speed # of Units Over Gassing Variable information outside of Static Protocol 18

The Executive Summary Report All data compiled on attachments from the validation batch protocol run, will be included in a Final Summary Report. The final report will present an analysis of the results and be reviewed for compliance and adherence to protocol acceptance criteria and batch record requirements. Each discrepancy shall be discussed in detail in the Discrepancy section of the Final Report and must include a statement of impact, if any, on the aseptic process and/or sterile filling suite. The Final Report will include a conclusion documenting that the sterile filling operation is capable of producing sterile filled vials and that the Aseptic Processing Area meets cgmp expectations, 21 CFR parts 210 and 211 regulations, and all internal requirements. 20

Comprehensive and Holistic Aseptic Controls Master Plan, Aseptic Processing Protocol and Executive Summary Report.the Goal Is: Comprehensive Defined / Documented Program Policies Procedures Start Global / End Local Support with Regulatory References Holistic Build on Data Systems Approach Roll Information Up Take Credit for Everything Sell your story Provide Immediate Picture of Compliance Don t Forget Training 21

Preparing your Facility Facility Design & First Impressions Understand your Process, Material, & Personnel Flows Practice your Tour Routes Pictures & Maps in Opening Presentation Plan to be in Operation 22

Facility Impressions One opportunity to make that impression Must Have Robust procedures and visible practices for facility maintenance Employee Driven Site Pride Management: Positive reinforcement Visible Messaging Mirrors Instructional and Reminder Placards 23

Facility Design : Understanding What Facility Design Understanding what You Are Up Against you are Up Against 24

Facility Design You get 1 opportunity to set the stage for your audit Facility must show well Process, Material, Personnel, and Waste flows must be documented through controlled drawings, approved SOP s, and documented practice. Surfaces must be visually cleanable and visually clean Assume all doors, drawers, cabinets will be opened 25

What s in? Facility Design Commissioning and Qualification of Facility Design and Qualification of Environmental Monitoring Strategy HVAC Smoke Profiles Cleaning & Disinfection Programs Qualification of Cleaning Agents on your surfaces using USP panel and your organisms Looks Clean is Clean? Utilities Design WFI / Purified Water.Back to Generation Compressed Gases 26

HVAC Building Monitoring System Operations monitored & alarmed 24/7 Visual Indicators light bar All rooms are monitored and alarmed independently. Minimum allowable room pressure 0.01inches W.C. Terminal HEPA s-99.97% ASHRAE rating Certified every 6 months- Integrity and Velocity (Unidirectional) Velocity at work surface Certified every 12 months- Filter Loading (Volume- Flow, used for room pressurization) Smoke Profiles; Static, Dynamic, w Change Control Minimum 20 air changes Total air changes is excess of 100 (make up and recirc. Included) 27

Process Utilities Water Criticality of Use- monitor / control back to Generation Monitor as-is Conditions (Tubing) Applicable Compendia Thermophiles Annual Summary Compressed Gases Point of Use Filtration Rationale for selected Sites Criticality of Use point Physical Logistics Time Driven Summary 28

Manufacturing Space Legacy State of the Art Products Conditions History 29

Process Filters: Regulatory Expectations FDA Expectations Validation Encompassing Chemical Compatibility Extractable / Leachable Determination Firm must conclude that levels are acceptable Microbial Retention Viability Determination Suggested Facilitation Tools Executive Summary Report Include all Process Filters 30

Support Area Space Cascade of Control Traffic Flow Automation vs. Manual 31

Impact to Controlled Environments Surfaces Air Water Personnel Manufacturing Environment Incoming Materials Facilities & Equipment 32

Microbial monitoring programs for controlled environments should assess the effectiveness of cleaning and sanitization practices by and of personnel that could have an impact on the bioburden of the controlled environment. Microbial monitoring, regardless of how sophisticated the system may be, will not and need not identify and quantitate all microbial contaminants present in these controlled environments. However, routine microbial monitoring should provide sufficient information to ascertain that the controlled environment is operating within an adequate state of control. Untied States Pharmacopeia General Chapter <1116> 33

Routine Monitoring: A Holistic Approach Environmental Monitoring HVAC Process Utilities Dynamic Manufacturing Process Disinfectant Program Personnel Monitoring Qualification Routine Bioburden / Endotoxin Monitoring Components Product Vendor Certification 34

You r Environmental Program Must Demonstrate a Holistic Program of Control Understand the Regulation (s) Requirements Applicability to your operation No more 209E-replaced with ISO standard in 1999 Understand your Process Requirements Weaknesses Strengths Emotional vs Technical concerns Understand the c in CGMP for your District and your Customers Stay Current, and be part of the review process! Your Environmental Monitoring Program must be designed as applicable to your unique needs 35

Risk Assessment Product Process Commodity Preparation Staging Holding Time Controlled Environment Cascade Air Flow Personnel Flow Product Flow 36

Bioburden and Endotoxin Document Formal Position Components-API and Excipients Commodities Formulated Solutions Pre filtration (Bulk solution) Post filling (pre- sterilization) sampled from end of fill Any recovered organisms are identified Heat Shock all Gram + Spore formers Defined Response to Gram - Objectionable Organisms 37

Approach and Control It s all about Negating the Risk Continuous Monitoring Isolation Technologies Certified Vendors Comprehensive Training Extra Sampling when Warranted Robust Trending CAPA 38

So What s a Legacy Facility to do? Negate the Risk through the implementation of Robust Monitoring and Data Collection Programs. Certified Vendors-Understand potential for introduction of Bioburden and Endotoxin Comprehensive Training-Clean room personnel are No. 1 source of contamination Extra Sampling when Warranted-Be sure programs contain detailed instructions for additional samples when OOS occurs Robust Trending-LIMS is now a must have CAPA-Procedurally ensure that all excursions are appropriately investigated. A count of (1) in a sea of zeros will be questioned. 39

Prepare your Employees Need to Document and Understand required Competencies Define and Support through Evidence- Contamination Control Subject Matter Experts Practice and Prepare for Regulatory Audits 40

Preparation Considerations Personnel Job Descriptions and Training Documentation Prepare Subject Matter Experts Microbiologists Controlled Environment Engineers The Art of the Audit Define and Prepare the Team Document your Opening Presentation Understand what will be Requested and have Immediately Available 41

Audit Facilitation Tips Don t wait until FDA at your Door to prepare Audit Ready All the Time Defined Audit Team and Procedure Prepared and printed Opening presentation Facility Overview with Pictures Organizational Charts Approved Drawings: Personnel, Material, Waste Flows and Controlled Environment Classes related to HVAC High Level Process Flows, CAPA Flow, Tools for managing Audit SharePoint or equivalent Prep Room Ready 42

Gowning Qualification Control Routine Monitoring Finger Impressions Garments Aseptic Personnel Disqualification Training Hygiene Basic Microbiology Simulations Program inclusive of all entering Controlled Environments 43

Aseptic Training Initial aseptic core certification requires: - SOP review and quiz - Aseptic Gowning Technique Presentation and quiz - Aseptic Manipulation Course and quiz - Microbial Orientation class and quiz - Aseptic Gowning certification Re-certification required for: Annual gown re-certification Re-occurring personnel monitoring OAL s Leave of absence over 3 months 44

Inspections Investigator will request reports associated with environmental trends. Provides -road into: Management Controls, MDR Design Controls, Change Control CAPA Production / Process Controls Trending: Open / Closed / Aging Product specific Across Process 45

Risk Assessment Inspector Will Expect Documented Risk Assessment, with identified Mitigations Aseptic Manufacturing Traditional Isolated Liquids vs. Powders Complexity: Liquid vs. Lyo. Multiple Shifts 46

Requests your Aseptic Audit team Must be able to Provide Please Provide a document that defines your facilities Aseptic Risk Assessment and Mitigation Strategy Please provide a documented Facility Design with considerations and rationale for: Materials, surfaces and finishes Please provide an Environmental Program Document with considerations and rationale for: Sample Sites Frequencies Disinfectants Please provide evidence that EM trends are reviewed annually and conclusions are documented don t forget the CAPA 47

Requests your Aseptic Audit team Must be able to Provide Please provide evidence that your aseptic processing simulation represents actual manufacturing operations Frequency, Duration, Parameters, and Conditions Statistical execution of Interventions Please provide a trend of all your controlled utilities for the last 2 years Please provide a trend of all bioburden monitoring for the last 2 years Please provide the qualifications and evidence of those qualifications for all Aseptic Operators and their Management 48

Tying it all Together Know the Requirements and Document how your Site Meets them.. Aseptic Controls Master Plan Aseptic Processing Protocols & Reports Prepare your Facility Understand Weaknesses Instill Site Pride Walk throughs multiple! Prepare your Employees Competencies Predefined Audit Team, Space & Tools 49

Getting Help: References FDA guidance Aseptic Processing Guideline EU-Orange Guide PDA Technical Report 13 USP General Chapters ISO 14644 series, replaced Fed. Std. 209E GMP Trends Industry Organizations and Publications IVT PMF PDA AAMI Discussion Groups 50

Questions? 51

Thank you! Valerie Welter Director Quality Management Bayer HealthCare Valerie.welter@Bayer.com